Forest Laboratories agreed to a $300 million settlement following allegations of off-label marketing lawsuit and illegal kickbacks. The lawsuit, which included $106 million in civil recovery, was brought by a whistleblower sales representative who exposed unethical sales practices.
The whistleblower, a former Forest sales representative, revealed that the company pressured sales staff to promote antidepressants for pediatric use, even though the drugs were not FDA-approved for children. Additionally, Forest Laboratories allegedly provided illegal kickbacks to incentivize physicians to prescribe these medications, violating federal law.
This case remains a landmark off-label marketing lawsuit, reinforcing the importance of whistleblowers in exposing pharmaceutical fraud. Read more about this case here.
If you have information about fraudulent practices, contact our office for a free, confidential consultation:
This article is for informational purposes only and should not be considered legal advice.
To determine whether you have a potential case, please complete the Case Evaluation form by clicking the button above, and a member of our team will contact you as soon as possible. To learn more about whistleblower protections, click here.
You don’t have to go it alone. Our attorneys have successfully represented whistleblowers in some of the largest fraud cases in the country, delivering real results while protecting our clients. Take the first step today.